Alert

Recommended Alerts

Sign Up For Alerts

Herbalife Agrees to Pay $123 Million to Settle Charges Related to 10-Year Bribery Scheme in China

Herbalife Nutrition Ltd.’s (“Herbalife”) recent settlement of bribery allegations demonstrates the U.S. government’s continuing focus on China and the critical role that board members and senior management of multinationals play in overseeing compliance globally. On August 28, 2020, Herbalife Nutrition Ltd. (“Herbalife”) agreed to pay the Securities and Exchange Commission (“SEC”) and the Department of Justice (“DOJ”) more than $123 million in penalties and disgorgement to resolve bribery allegations in China. The settlement resolves a long-running probe in which two former executives of Herbalife’s Chinese subsidiary were indicted on criminal charges in November 2019. The resolution is one of many recent noteworthy enforcement resolutions targeting the operations of multinationals in China.

Read More

FDA Chemist Charged With Trading On Confidential Information Related To Drug Approvals

Practices: Government Enforcement / White Collar Criminal Defense, Life Sciences, Corporate & Securities Litigation, Securities & Public Companies

Printer-Friendly Version

Cookie Settings